Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Neurodiversity takes centre stage at Oxford’s first conference

Oxford’s first Neurodiversity Conference brought together clinicians, researchers, local organisations members of the public and the neurodivergent community to discuss current and future research and areas for potential collaboration.

People attending the conference

The event was hosted by the NIHR Oxford Health Biomedical Research Centre (OH BRC). Day one of the two-day event at the Saïd Business School focused on research, while day two was dedicated to lived experience, and was hosted at Oxford University's Department of Psychiatry.

The event included flash talks and panel discussions on topics including:

  • adapting mental health interventions for neurodivergent individuals
  • lived experience in action
  • mental health support and co-occurring conditions
  • mechanistic approaches to mental health and neurodiversity
  • working with families.

 

Read the full story on the Department of Psychiatry website.

Similar stories

Statins do not cause the majority of side effects listed in package leaflets

Statins do not cause the majority of the conditions that have been listed in their package leaflets, including memory loss, depression, sleep disturbance, and erectile and sexual dysfunction, according to the most comprehensive review of possible side effects. The study was led by researchers at the Nuffield Department of Population Health and published in The Lancet.

New Oxford-led initiative launches to train future leaders in transformative technologies for pharmaceutical research

Professor Sir Nicholas White OBE KCMG FRS

Long-overlooked cerebral cortical cell layer may hold key to attention

National Perinatal Epidemiology Unit officially joins the Nuffield Department of Women’s & Reproductive Health

Oxford spinout launches AI-based ultrasound technology to improve early detection of pregnancy complications